Latest Strategy News

Lithium Universe Limited has acquired exclusive global rights to a pioneering microwave-based technology for recycling photovoltaic solar panels, offering a strategic pivot while awaiting lithium market recovery.

Lithium Universe has acquired exclusive global rights to a pioneering microwave-based solar panel recycling technology from Macquarie University, aiming to revolutionize critical metal recovery and sustainability in the solar industry.

Aquirian Limited unveils a strategic growth plan centered on its Wubin Energetics hub and proprietary Collar Keeper® technology, aiming to boost revenue and operational efficiency amid rising mining demand.

Morella Corporation has initiated a pioneering rubidium extraction study with Edith Cowan University and secured key approvals for development drilling at its Mt Edon Project, setting the stage for a maiden mineral resource estimate.

Lumos Diagnostics has enrolled 500 patients in its FebriDx CLIA waiver clinical study, unlocking a significant milestone payment from BARDA and moving closer to FDA approval that could open a US$1 billion market.

Staude Capital Global Value Fund Limited (GVF) launches a Share Purchase Plan offering existing shareholders a chance to invest up to $30,000 at a price near its net asset value, following nearly five years without a capital raise.

Viva Leisure has grown from 29 gyms in 2019 to over 480 locations, leveraging proprietary technology and a multi-brand strategy to lead fitness innovation across Australia and beyond.

Viva Leisure has launched a refreshed corporate brand and published 'The Viva Story,' outlining its transformation into a global, technology-driven fitness ecosystem.

Askari Metals is advancing its African exploration strategy with detailed field campaigns targeting tin, tantalum, and gold mineralisation in Namibia and Ethiopia, while evaluating strategic acquisitions to bolster its portfolio.

X2M Connect Limited has secured $1.95 million through a share placement and convertible note conversion, aiming to strengthen its balance sheet and accelerate growth in AI and IoT sectors.

CLINUVEL’s Phase II pilot study reveals afamelanotide monotherapy does not trigger repigmentation in vitiligo patients, underscoring the necessity of adjunct NB-UVB phototherapy.

Ionic Rare Earths is broadening its Viridion Joint Venture to include a US-based rare earth refinery, aiming to strengthen a secure supply chain for critical magnet and heavy rare earth oxides outside China.